Priapizm
Özet
Referanslar
Ericson C, Baird B, Broderick GA, et al. Management of Priapism: 2021 Update. Urologic Clinics of North America. 2021;48(4):565-576. doi: 10.1016/j.ucl.2021.07.003
Fantus RJ, Brannigan RE, Davis AM. Diagnosis and Management of Priapism. The Journal of the American Medical Association. 2023;330(6):559-560. doi: 10.1001/jama.2023.13377
Harvey M, Chislett B, Perera M, et al. High-flow post-traumatic priapism with delayed presentation. BMJ case reports. 2022;15(4):e249513. doi: 10.1136/bcr-2022-249513
Broderick GA, Kadioglu A, Bivalacqua TJ, et al. Priapism: pathogenesis, epidemiology, and management. The Journal of Sexual Medicine. 2010;7(1 Pt 2):476-500. doi: 10.1111/j.1743-6109.2009.01625.x
Hoeh MP, Levine LA. Management of Recurrent Ischemic Priapism 2014: A Complex Condition with Devastating Consequences. Sexual Medicine Reviews. 2015;3(1):24-35. doi: 10.1002/smrj.37
Lumbiganon S, Moukhtar Hammad MA, Azad B, et al. A narrative review of initial treatment for ischemic priapism. International Journal of Impotence Research. 2024. doi: 10.1038/s41443-024-00951-1
Berger R, Billups K, Brock G, et al. Report of the American Foundation for Urologic Disease (AFUD) Thought Leader Panel for evaluation and treatment of priapism. International Journal of Impotence Research. 2001;13 Suppl 5:S39-43. doi: 10.1038/sj.ijir.3900777
Pohl J, Pott B, Kleinhans G. Priapism: a three-phase concept of management according to aetiology and prognosis. British Journal of Urology. 1986;58(2):113-118. doi: 10.1111/j.1464-410x.1986.tb09008.x
Nelson JH, Winter CC. Priapism: evolution of management in 48 patients in a 22-year series. The Journal of Urology. 1977;117(4):455-458. doi: 10.1016/s0022-5347(17)58497-9
Ateyah A, Rahman El-Nashar A, Zohdy W, et al. Intracavernosal irrigation by cold saline as a simple method of treating iatrogenic prolonged erection. The Journal of Sexual Medicine. 2005;2(2):248-253. doi: 10.1111/j.1743-6109.2005.20235.x
Bivalacqua TJ, Musicki B, Kutlu O, et al. New insights into the pathophysiology of sickle cell disease-associated priapism. The Journal of Sexual Medicine. 2012;9(1):79-87. doi: 10.1111/j.1743-6109.2011.02288.x
Coombs PG, Heck M, Guhring P, et al. A review of outcomes of an intracavernosal injection therapy programme. BJU international. 2012;110(11):1787-1791. doi: 10.1111/j.1464-410X.2012.11080.x
El-Bahnasawy MS, Dawood A, Farouk A. Low-flow priapism: risk factors for erectile dysfunction. BJU international. 2002;89(3):285-290. doi: 10.1046/j.1464-4096.2001.01510.x
Porst H. The rationale for prostaglandin E1 in erectile failure: a survey of worldwide experience. The Journal of Urology. 1996;155(3):802-815.
Jünemann KP, Persson-Jünemann C, Alken P. Pathophysiology of erectile dysfunction. Seminars in Urology. 1990;8(2):80-93.
Kilic M, Serefoglu EC, Ozdemir AT, et al. The actual incidence of papaverine-induced priapism in patients with erectile dysfunction following penile colour Doppler ultrasonography. Andrologia. 2010;42(1):1-4. doi: 10.1111/j.1439-0272.2009.00940.x
Bschleipfer TH, Hauck EW, Diemer TH, et al. Heparin-induced priapism. International Journal of Impotence Research. 2001;13(6):357-359. doi: 10.1038/sj.ijir.3900759
Chang MW, Tang CC, Chang SS. Priapism--a rare presentation in chronic myeloid leukemia: case report and review of the literature. Chang Gung Medical Journal. 2003;26(4):288-292.
EAU Guidelines. Edn. presented at the EAU Annual Congress, Paris 2024. ISBN 978-94-92671-23-3.
Jesus LE de, Dekermacher S. Priapism in children: review of pathophysiology and treatment. Jornal De Pediatria. 2009;85(3):194-200. doi: 10.2223/JPED.1897
Witt MA, Goldstein I, Saenz de Tejada I, et al. Traumatic laceration of intracavernosal arteries: the pathophysiology of nonischemic, high flow, arterial priapism. The Journal of Urology. 1990;143(1):129-132. doi: 10.1016/s0022-5347(17)39889-0
Dubocq FM, Tefilli MV, Grignon DJ, et al. High flow malignant priapism with isolated metastasis to the corpora cavernosa. Urology. 1998;51(2):324-326. doi: 10.1016/s0090-4295(97)00607-9
Burgu B, Talas H, Erdeve O, et al. Approach to newborn priapism: a rare entity. Journal of Pediatric Urology. 2007;3(6):509-511. doi: 10.1016/j.jpurol.2007.06.007
Liguori G, Garaffa G, Trombetta C, et al. High-flow priapism (HFP) secondary to Nesbit operation: management by percutaneous embolization and colour Doppler-guided compression. International Journal of Impotence Research. 2005;17(3):304-306. doi: 10.1038/sj.ijir.3901251
James Johnson M, Hallerstrom M, Alnajjar HM, et al. Which patients with ischaemic priapism require further investigation for malignancy? International Journal of Impotence Research. 2020;32(2):195-200. doi: 10.1038/s41443-019-0141-z
Morrison BF, Anele UA, Reid MEve ark. Is testosterone deficiency a possible risk factor for priapism associated with sickle-cell disease? International Urology and Nephrology. 2015;47(1):47-52. doi: 10.1007/s11255-014-0864-1
Muneer A, Cellek S, Dogan A, et al. Investigation of cavernosal smooth muscle dysfunction in low flow priapism using an in vitro model. International Journal of Impotence Research. 2005;17(1):10-18. doi: 10.1038/sj.ijir.3901231
Vreugdenhil S, Freire Jorge PJ, van Driel MF, et al. Ischemic priapism as a model of exhausted metabolism. Physiological Reports. 2019;7(6):e13999. doi: 10.14814/phy2.13999
Spycher MA, Hauri D. The ultrastructure of the erectile tissue in priapism. The Journal of Urology. 1986;135(1):142-147. doi: 10.1016/s0022-5347(17)45549-2
Costa WS, Felix B, Cavalcanti AG, et al. Structural analysis of the corpora cavernosa in patients with ischaemic priapism. BJU international. 2010;105(6):838-841. doi: 10.1111/j.1464-410X.2009.08871.x
Jin YC, Gam SC, Jung JH, et al. Expression and activity of heme oxygenase-1 in artificially induced low-flow priapism in rat penile tissues. The Journal of Sexual Medicine. 2008;5(8):1876-1882. doi: 10.1111/j.1743-6109.2008.00886.x
Moreland RB, Traish A, McMillin MA, et al. PGE1 suppresses the induction of collagen synthesis by transforming growth factor-beta 1 in human corpus cavernosum smooth muscle. The Journal of Urology. 1995;153(3 Pt 1):826-834.
Bivalacqua TJ, Diner EK, Novak TE, et al. A rat model of Peyronie’s disease associated with a decrease in erectile activity and an increase in inducible nitric oxide synthase protein expression. The Journal of Urology. 2000;163(6):1992-1998.
Bertolotto M, Zappetti R, Pizzolato R, et al. Color Doppler appearance of penile cavernosal-spongiosal communications in patients with high-flow priapism. Acta Radiologica (Stockholm, Sweden: 1987). 2008;49(6):710-714. doi: 10.1080/02841850802027026
Bastuba MD, Saenz de Tejada I, Dinlenc CZ, et al. Arterial priapism: diagnosis, treatment and long-term followup. The Journal of Urology. 1994;151(5):1231-1237. doi: 10.1016/s0022-5347(17)35219-9
Hakim LS, Kulaksizoglu H, Mulligan R, et al. Evolving concepts in the diagnosis and treatment of arterial high flow priapism. The Journal of Urology. 1996;155(2):541-548.
Montague DK, Jarow J, Broderick GA, et al. American Urological Association guideline on the management of priapism. The Journal of Urology. 2003;170(4 Pt 1):1318-1324. doi: 10.1097/01.ju.0000087608.07371.ca
Kirkham APS, Illing RO, Minhas S, et al. MR imaging of nonmalignant penile lesions. Radiographics: A Review Publication of the Radiological Society of North America, Inc. 2008;28(3):837-853. doi: 10.1148/rg.283075100
Ralph DJ, Garaffa G, Muneer A, et al. The immediate insertion of a penile prosthesis for acute ischaemic priapism. European Urology. 2009;56(6):1033-1038. doi: 10.1016/j.eururo.2008.09.044
Zacharakis E, Garaffa G, Raheem AA, et al. Penile prosthesis insertion in patients with refractory ischaemic priapism: early vs delayed implantation. BJU international. 2014;114(4):576-581. doi: 10.1111/bju.12686
Burnett AL, Sharlip ID. Standard operating procedures for priapism. The Journal of Sexual Medicine. 2013;10(1):180-194. doi: 10.1111/j.1743-6109.2012.02707.x
Davila HH, Parker J, Webster JC, et al. Subarachnoid hemorrhage as complication of phenylephrine injection for the treatment of ischemic priapism in a sickle cell disease patient. The Journal of Sexual Medicine. 2008;5(4):1025-1028. doi: 10.1111/j.1743-6109.2007.00715.x
Roberts J, Isenberg DL. Adrenergic crisis after penile epinephrine injection for priapism. The Journal of Emergency Medicine. 2009;36(3):309-310. doi: 10.1016/j.jemermed.2007.10.024
Lee M, Cannon B, Sharifi R. Chart for preparation of dilutions of alpha-adrenergic agonists for intracavernous use in treatment of priapism. The Journal of Urology. 1995;153(4):1182-1183.
Muruve N, Hosking DH. Intracorporeal phenylephrine in the treatment of priapism. The Journal of Urology. 1996;155(1):141-143.
Dittrich A, Albrecht K, Bar-Moshe O, et al. Treatment of pharmacological priapism with phenylephrine. The Journal of Urology. 1991;146(2):323-324. doi: 10.1016/s0022-5347(17)37781-9
Wen CC, Munarriz R, McAuley I, et al. Management of ischemic priapism with high-dose intracavernosal phenylephrine: from bench to bedside. The Journal of Sexual Medicine. 2006;3(5):918-922. doi: 10.1111/j.1743-6109.2005.00140.x
Lowe FC, Jarow JP. Placebo-controlled study of oral terbutaline and pseudoephedrine in management of prostaglandin E1-induced prolonged erections. Urology. 1993;42(1):51-53. doi: 10.1016/0090-4295(93)90338-b
Priyadarshi S. Oral terbutaline in the management of pharmacologically induced prolonged erection. International Journal of Impotence Research. 2004;16(5):424-426. doi: 10.1038/sj.ijir.3901180
Johnson MJ, Kristinsson S, Ralph O, et al. The surgical management of ischaemic priapism. International Journal of Impotence Research. 2020;32(1):81-88. doi: 10.1038/s41443-019-0197-9
Referanslar
Ericson C, Baird B, Broderick GA, et al. Management of Priapism: 2021 Update. Urologic Clinics of North America. 2021;48(4):565-576. doi: 10.1016/j.ucl.2021.07.003
Fantus RJ, Brannigan RE, Davis AM. Diagnosis and Management of Priapism. The Journal of the American Medical Association. 2023;330(6):559-560. doi: 10.1001/jama.2023.13377
Harvey M, Chislett B, Perera M, et al. High-flow post-traumatic priapism with delayed presentation. BMJ case reports. 2022;15(4):e249513. doi: 10.1136/bcr-2022-249513
Broderick GA, Kadioglu A, Bivalacqua TJ, et al. Priapism: pathogenesis, epidemiology, and management. The Journal of Sexual Medicine. 2010;7(1 Pt 2):476-500. doi: 10.1111/j.1743-6109.2009.01625.x
Hoeh MP, Levine LA. Management of Recurrent Ischemic Priapism 2014: A Complex Condition with Devastating Consequences. Sexual Medicine Reviews. 2015;3(1):24-35. doi: 10.1002/smrj.37
Lumbiganon S, Moukhtar Hammad MA, Azad B, et al. A narrative review of initial treatment for ischemic priapism. International Journal of Impotence Research. 2024. doi: 10.1038/s41443-024-00951-1
Berger R, Billups K, Brock G, et al. Report of the American Foundation for Urologic Disease (AFUD) Thought Leader Panel for evaluation and treatment of priapism. International Journal of Impotence Research. 2001;13 Suppl 5:S39-43. doi: 10.1038/sj.ijir.3900777
Pohl J, Pott B, Kleinhans G. Priapism: a three-phase concept of management according to aetiology and prognosis. British Journal of Urology. 1986;58(2):113-118. doi: 10.1111/j.1464-410x.1986.tb09008.x
Nelson JH, Winter CC. Priapism: evolution of management in 48 patients in a 22-year series. The Journal of Urology. 1977;117(4):455-458. doi: 10.1016/s0022-5347(17)58497-9
Ateyah A, Rahman El-Nashar A, Zohdy W, et al. Intracavernosal irrigation by cold saline as a simple method of treating iatrogenic prolonged erection. The Journal of Sexual Medicine. 2005;2(2):248-253. doi: 10.1111/j.1743-6109.2005.20235.x
Bivalacqua TJ, Musicki B, Kutlu O, et al. New insights into the pathophysiology of sickle cell disease-associated priapism. The Journal of Sexual Medicine. 2012;9(1):79-87. doi: 10.1111/j.1743-6109.2011.02288.x
Coombs PG, Heck M, Guhring P, et al. A review of outcomes of an intracavernosal injection therapy programme. BJU international. 2012;110(11):1787-1791. doi: 10.1111/j.1464-410X.2012.11080.x
El-Bahnasawy MS, Dawood A, Farouk A. Low-flow priapism: risk factors for erectile dysfunction. BJU international. 2002;89(3):285-290. doi: 10.1046/j.1464-4096.2001.01510.x
Porst H. The rationale for prostaglandin E1 in erectile failure: a survey of worldwide experience. The Journal of Urology. 1996;155(3):802-815.
Jünemann KP, Persson-Jünemann C, Alken P. Pathophysiology of erectile dysfunction. Seminars in Urology. 1990;8(2):80-93.
Kilic M, Serefoglu EC, Ozdemir AT, et al. The actual incidence of papaverine-induced priapism in patients with erectile dysfunction following penile colour Doppler ultrasonography. Andrologia. 2010;42(1):1-4. doi: 10.1111/j.1439-0272.2009.00940.x
Bschleipfer TH, Hauck EW, Diemer TH, et al. Heparin-induced priapism. International Journal of Impotence Research. 2001;13(6):357-359. doi: 10.1038/sj.ijir.3900759
Chang MW, Tang CC, Chang SS. Priapism--a rare presentation in chronic myeloid leukemia: case report and review of the literature. Chang Gung Medical Journal. 2003;26(4):288-292.
EAU Guidelines. Edn. presented at the EAU Annual Congress, Paris 2024. ISBN 978-94-92671-23-3.
Jesus LE de, Dekermacher S. Priapism in children: review of pathophysiology and treatment. Jornal De Pediatria. 2009;85(3):194-200. doi: 10.2223/JPED.1897
Witt MA, Goldstein I, Saenz de Tejada I, et al. Traumatic laceration of intracavernosal arteries: the pathophysiology of nonischemic, high flow, arterial priapism. The Journal of Urology. 1990;143(1):129-132. doi: 10.1016/s0022-5347(17)39889-0
Dubocq FM, Tefilli MV, Grignon DJ, et al. High flow malignant priapism with isolated metastasis to the corpora cavernosa. Urology. 1998;51(2):324-326. doi: 10.1016/s0090-4295(97)00607-9
Burgu B, Talas H, Erdeve O, et al. Approach to newborn priapism: a rare entity. Journal of Pediatric Urology. 2007;3(6):509-511. doi: 10.1016/j.jpurol.2007.06.007
Liguori G, Garaffa G, Trombetta C, et al. High-flow priapism (HFP) secondary to Nesbit operation: management by percutaneous embolization and colour Doppler-guided compression. International Journal of Impotence Research. 2005;17(3):304-306. doi: 10.1038/sj.ijir.3901251
James Johnson M, Hallerstrom M, Alnajjar HM, et al. Which patients with ischaemic priapism require further investigation for malignancy? International Journal of Impotence Research. 2020;32(2):195-200. doi: 10.1038/s41443-019-0141-z
Morrison BF, Anele UA, Reid MEve ark. Is testosterone deficiency a possible risk factor for priapism associated with sickle-cell disease? International Urology and Nephrology. 2015;47(1):47-52. doi: 10.1007/s11255-014-0864-1
Muneer A, Cellek S, Dogan A, et al. Investigation of cavernosal smooth muscle dysfunction in low flow priapism using an in vitro model. International Journal of Impotence Research. 2005;17(1):10-18. doi: 10.1038/sj.ijir.3901231
Vreugdenhil S, Freire Jorge PJ, van Driel MF, et al. Ischemic priapism as a model of exhausted metabolism. Physiological Reports. 2019;7(6):e13999. doi: 10.14814/phy2.13999
Spycher MA, Hauri D. The ultrastructure of the erectile tissue in priapism. The Journal of Urology. 1986;135(1):142-147. doi: 10.1016/s0022-5347(17)45549-2
Costa WS, Felix B, Cavalcanti AG, et al. Structural analysis of the corpora cavernosa in patients with ischaemic priapism. BJU international. 2010;105(6):838-841. doi: 10.1111/j.1464-410X.2009.08871.x
Jin YC, Gam SC, Jung JH, et al. Expression and activity of heme oxygenase-1 in artificially induced low-flow priapism in rat penile tissues. The Journal of Sexual Medicine. 2008;5(8):1876-1882. doi: 10.1111/j.1743-6109.2008.00886.x
Moreland RB, Traish A, McMillin MA, et al. PGE1 suppresses the induction of collagen synthesis by transforming growth factor-beta 1 in human corpus cavernosum smooth muscle. The Journal of Urology. 1995;153(3 Pt 1):826-834.
Bivalacqua TJ, Diner EK, Novak TE, et al. A rat model of Peyronie’s disease associated with a decrease in erectile activity and an increase in inducible nitric oxide synthase protein expression. The Journal of Urology. 2000;163(6):1992-1998.
Bertolotto M, Zappetti R, Pizzolato R, et al. Color Doppler appearance of penile cavernosal-spongiosal communications in patients with high-flow priapism. Acta Radiologica (Stockholm, Sweden: 1987). 2008;49(6):710-714. doi: 10.1080/02841850802027026
Bastuba MD, Saenz de Tejada I, Dinlenc CZ, et al. Arterial priapism: diagnosis, treatment and long-term followup. The Journal of Urology. 1994;151(5):1231-1237. doi: 10.1016/s0022-5347(17)35219-9
Hakim LS, Kulaksizoglu H, Mulligan R, et al. Evolving concepts in the diagnosis and treatment of arterial high flow priapism. The Journal of Urology. 1996;155(2):541-548.
Montague DK, Jarow J, Broderick GA, et al. American Urological Association guideline on the management of priapism. The Journal of Urology. 2003;170(4 Pt 1):1318-1324. doi: 10.1097/01.ju.0000087608.07371.ca
Kirkham APS, Illing RO, Minhas S, et al. MR imaging of nonmalignant penile lesions. Radiographics: A Review Publication of the Radiological Society of North America, Inc. 2008;28(3):837-853. doi: 10.1148/rg.283075100
Ralph DJ, Garaffa G, Muneer A, et al. The immediate insertion of a penile prosthesis for acute ischaemic priapism. European Urology. 2009;56(6):1033-1038. doi: 10.1016/j.eururo.2008.09.044
Zacharakis E, Garaffa G, Raheem AA, et al. Penile prosthesis insertion in patients with refractory ischaemic priapism: early vs delayed implantation. BJU international. 2014;114(4):576-581. doi: 10.1111/bju.12686
Burnett AL, Sharlip ID. Standard operating procedures for priapism. The Journal of Sexual Medicine. 2013;10(1):180-194. doi: 10.1111/j.1743-6109.2012.02707.x
Davila HH, Parker J, Webster JC, et al. Subarachnoid hemorrhage as complication of phenylephrine injection for the treatment of ischemic priapism in a sickle cell disease patient. The Journal of Sexual Medicine. 2008;5(4):1025-1028. doi: 10.1111/j.1743-6109.2007.00715.x
Roberts J, Isenberg DL. Adrenergic crisis after penile epinephrine injection for priapism. The Journal of Emergency Medicine. 2009;36(3):309-310. doi: 10.1016/j.jemermed.2007.10.024
Lee M, Cannon B, Sharifi R. Chart for preparation of dilutions of alpha-adrenergic agonists for intracavernous use in treatment of priapism. The Journal of Urology. 1995;153(4):1182-1183.
Muruve N, Hosking DH. Intracorporeal phenylephrine in the treatment of priapism. The Journal of Urology. 1996;155(1):141-143.
Dittrich A, Albrecht K, Bar-Moshe O, et al. Treatment of pharmacological priapism with phenylephrine. The Journal of Urology. 1991;146(2):323-324. doi: 10.1016/s0022-5347(17)37781-9
Wen CC, Munarriz R, McAuley I, et al. Management of ischemic priapism with high-dose intracavernosal phenylephrine: from bench to bedside. The Journal of Sexual Medicine. 2006;3(5):918-922. doi: 10.1111/j.1743-6109.2005.00140.x
Lowe FC, Jarow JP. Placebo-controlled study of oral terbutaline and pseudoephedrine in management of prostaglandin E1-induced prolonged erections. Urology. 1993;42(1):51-53. doi: 10.1016/0090-4295(93)90338-b
Priyadarshi S. Oral terbutaline in the management of pharmacologically induced prolonged erection. International Journal of Impotence Research. 2004;16(5):424-426. doi: 10.1038/sj.ijir.3901180
Johnson MJ, Kristinsson S, Ralph O, et al. The surgical management of ischaemic priapism. International Journal of Impotence Research. 2020;32(1):81-88. doi: 10.1038/s41443-019-0197-9
